Biodesix, Inc. reaffirmed revenue guidance for the year 2023. For the year, the company expects total revenue to be between $52 million to $55 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.525 USD | +2.01% | -1.61% | -17.12% |
13/05 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
08/05 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.12% | 170M | |
-16.80% | 8.79B | |
+67.50% | 4.19B | |
-4.03% | 2.48B | |
-42.54% | 2.29B | |
-6.49% | 1.97B | |
-20.45% | 1.56B | |
-41.24% | 1.22B | |
+10.26% | 1.13B | |
+18.74% | 933M |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Reaffirms Revenue Guidance for the Year 2023